Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
|Articles|March 18, 2010
- March 2010 Central Nervous System
- Volume 76
- Issue 3
Pharmacist's Guide to Medical Marijuana
Advertisement
The content on this page has moved.
Photo Courtesy of Oncology & Biotech News
To read "A Pharmacist's Guide to Medical Marijuana" and leave comments, please go to:
Articles in this issue
over 16 years ago
March Online Exclusivesover 16 years ago
Arthritis Watchover 16 years ago
Hypertension Watchover 16 years ago
CNS Watchover 16 years ago
Understanding Alzheimer'sover 16 years ago
Tourette's Syndrome: A Common but Treatable Conditionover 16 years ago
Tech Product Newsover 16 years ago
Pharmacy Technology Newsover 16 years ago
Specialty Pharmaceuticals: Immunoglobulin TherapyAdvertisement
Related to this article
Pharmacists make a difference in patients’ lives through MTM services.
Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.
AI tools in pharmacy education risk eroding critical thinking, lab competency, and patient safety if used as substitutes for foundational learning.
Each October, the pharmacy profession pauses to recognize technicians' decades-long evolution, from on-the-job trainees to nationally certified health care professionals.
Peer Reviewed
Creating institution-specific, literacy-friendly chemotherapy education sheets resulted in patient education materials with higher readability scores than similar materials from common chemotherapy education sites.
In an era of rapidly evolving technology, we remain in a people-powered world.
How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
Breast Cancer Treatment Ends, But The Medication Questions Don’t
5